Alyeska Investment Group
RMD icon

Alyeska Investment Group’s ResMed RMD Stock Holding History

Alyeska Investment Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-387,610
Closed -$80.7M – 533
2022
Q4 		$80.7M Buy
387,610
+182,605
+89% +$40.1M 0.83% 24
2022
Q3 		$44.8M Buy
+205,005
New +$46.7M 0.52% 62
2021
Q3 		– Sell
-234,053
Closed -$57.7M – 776
2021
Q2 		$57.7M Buy
+234,053
New +$49.2M 0.67% 25
2015
Q2 		– Sell
-497,965
Closed -$35.7M – 556
2015
Q1 		$35.7M Sell
497,965
-107,282
-18% -$6.97M 0.5% 54
2014
Q4 		$33.9M Buy
+605,247
New +$31.6M 0.58% 46
2013
Q4 		– Sell
-183,337
Closed -$9.68M – 368
2013
Q3 		$9.68M Hold
183,337
– – 0.4% 92
2013
Q2 		$8.27M Buy
+183,337
New +$8.7M 0.41% 80

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alyeska Investment Group's RMD Position: Q1 2023 in Review

Alyeska Investment Group sold out of ResMed (RMD) in Q1 2023, closing a stake of 387,610 shares — an estimated $80.7M sold.

Alyeska Investment Group first reported a position in RMD in Q2 2013 and held it in 7 quarters. The position peaked at $80.7M in Q4 2022. 676 funds tracked by Wall St. Rank hold RMD as of Q1 2023.

  • Alyeska Investment Group reported no remaining ResMed position as of Q1 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 387,610 ResMed shares in Q1 2023, an estimated $80.7M.
  • Alyeska Investment Group first reported a position in ResMed in Q2 2013 and held it in 7 quarters.
  • Alyeska Investment Group's ResMed position peaked at $80.7M in Q4 2022.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q1 2023.

Based on Alyeska Investment Group's 13F filing for Q1 2023, filed 15 May 2023.